Literature DB >> 18288395

The progression of gliomas is associated with cancer stem cell phenotype.

Doo-Sik Kong1, Mi Hyun Kim, Woong-Yang Park, Yeon-Lim Suh, Jung-Il Lee, Kwan Park, Jong Hyun Kim, Do-Hyun Nam.   

Abstract

Since cancer stem cells in brain tumors were introduced, there have been few explanations regarding the role of cancer stem cells in the progression of glioma. Here, we investigated their major molecular changes in tumor progression in relation to the stem cell subpopulation. Using 12 surgical specimens of gliomatosis cerebri (GC) in the early and advanced stages, we measured the expression of a panel of cell proliferation, microvessel density, microvessel areas, angiogenic factors and their associated receptors. In addition, expression of neural stem cell markers and associated cytokines were examined in tumor tissues by quantitative real-time RT-PCR. Comparing the biological characteristics between the initial infiltrating lesions (n=7) and progressed lesions (n=5), Sox2 and Musashi-1 were expressed in the tumor tissue at an early and a progressed state. Contrary to the early infiltrative phase representing angiogenesis-independent growth, GC with progression showed that nestin (+), PCNA (+) cells and total vessel area (angioectasia) were markedly increased with a higher expression of proangiogenic molecules and their receptors. These results suggest that tumor progression is mediated by cancer stem cells and cross-talk of cancer stem cells along with their environment and are closely associated with angiogenesis-dependent progression and -independent growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288395

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

1.  Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.

Authors:  Xuqun Tang; Yu Yao; Jingjing Zhu; Kunlin Jin; Yin Wang; Ying Mao; Liangfu Zhou
Journal:  Childs Nerv Syst       Date:  2012-07-20       Impact factor: 1.475

Review 2.  Sox2: regulation of expression and contribution to brain tumors.

Authors:  Sheila Mansouri; Romina Nejad; Merve Karabork; Can Ekinci; Ihsan Solaroglu; Kenneth D Aldape; Gelareh Zadeh
Journal:  CNS Oncol       Date:  2016-05-27

3.  PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.

Authors:  Ru-Bin Cheng; Rui-Juan Ma; Zhao-Kai Wang; Shan-Jun Yang; Xiang-Zhi Lin; Hui Rong; Yong Ma
Journal:  Mol Cell Biochem       Date:  2010-11-26       Impact factor: 3.396

4.  Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis.

Authors:  Tenley C Archer; Jing Jin; Elena S Casey
Journal:  Dev Biol       Date:  2010-12-11       Impact factor: 3.582

Review 5.  Targeting stem cells-clinical implications for cancer therapy.

Authors:  Lan Chun Tu; Greg Foltz; Edward Lin; Leroy Hood; Qiang Tian
Journal:  Curr Stem Cell Res Ther       Date:  2009-05       Impact factor: 3.828

Review 6.  The bright and the dark sides of DNA repair in stem cells.

Authors:  Guido Frosina
Journal:  J Biomed Biotechnol       Date:  2010-04-08

7.  Impact of adjuvant chemotherapy for gliomatosis cerebri.

Authors:  Doo-Sik Kong; Sung Tae Kim; Jung-Il Lee; Yeon-Lim Suh; Do Hoon Lim; Won Seog Kim; Ki-Hoon Kwon; Kwan Park; Jong Hyun Kim; Do-Hyun Nam
Journal:  BMC Cancer       Date:  2010-08-13       Impact factor: 4.430

Review 8.  Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?

Authors:  Isabelle Germano; Victoria Swiss; Patrizia Casaccia
Journal:  Neuropharmacology       Date:  2010-01-01       Impact factor: 5.250

9.  Three meta-analyses define a set of commonly overexpressed genes from microarray datasets on astrocytomas.

Authors:  Zhongyu Liu; Mengyu Xie; Zhiqiang Yao; Yulong Niu; Youquan Bu; Chunfang Gao
Journal:  Mol Neurobiol       Date:  2012-11-08       Impact factor: 5.590

Review 10.  Musashi-1-A Stemness RBP for Cancer Therapy?

Authors:  Nadine Bley; Ali Hmedat; Simon Müller; Robin Rolnik; Alexander Rausch; Marcell Lederer; Stefan Hüttelmaier
Journal:  Biology (Basel)       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.